A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Flow Cytometric Analysis of Extracellular Vesicles from Cell-conditioned Media

13.6K views

DOI:

10.3791/59128

February 12th, 2019

* These authors contributed equally

In This Article

Summary

The protocol describes a reproducible method designed for use with cell culture supernatants to detect surface epitopes on small extracellular vesicles (EV). It utilizes specific EV immunoprecipitation using beads coupled with antibodies that recognize surface antigen CD9, CD63, and CD81. The method is optimized for downstream flow cytometry analysis.

Abstract

Flow cytometry (FC) is the method of choice for semi-quantitative measurement of cell-surface antigen markers. Recently, this technique has been used for phenotypic analyses of extracellular vesicles (EV) including exosomes (Exo) in the peripheral blood and other body fluids. The small size of EV mandates the use of dedicated instruments having a detection threshold around 50-100 nm. Alternatively, EV can be bound to latex microbeads that can be detected by FC. Microbeads, conjugated with antibodies that recognize EV-associated markers/Cluster of Differentiation CD63, CD9, and CD81 can be used for EV capture. Exo isolated from CM can be analyzed with or without pre-enrichment by ultracentrifugation. This approach is suitable for EV analyses using conventional FC instruments. Our results demonstrate a linear correlation between Mean Fluorescence Intensity (MFI) values and EV concentration. Disrupting EV through sonication dramatically decreased MFI, indicating that the method does not detect membrane debris. We report an accurate and reliable method for the analysis of EV surface antigens, which can be easily implemented in any laboratory.

Introduction

Cells secrete extracellular vesicles (EV) of different sizes including microvesicles (MV) and exosomes (Exo). The latter can be distinguished from MV by both size and the subcellular compartment of origin. MV (200–1,000 nm in size) are released from parent cells by shedding from the plasma membrane. Conversely, Exo (30–150 nm) originate from endosomal membranes and are released into the extracellular space when the multivesicular bodies (MVB) fuse with the cell membrane1,2.

EV are increasingly used as diagnostic biomarkers as well as, potentially, therapeutic tools in ma....

Access restricted. Please log in or start a trial to view this content.

Protocol

1. Collection and Processing of Conditioned Media

  1. Coat 55 cm2 Petri dishes with 0.02% porcine skin gelatin in PBS.
  2. Plate CPC (8,000/cm2) in pre-coated dishes with 7 mL of Iscove's Modified Dulbecco's Medium (IMDM) supplemented with 20% FBS (Fetal Bovine Serum) and 1% Penicillin/Streptomycin (P/S).
    NOTE: The term “CPC” refers to human explant derived cells that have been described elsewhere14. CM can be collected from different cell types cultured in specific culture conditions. Wear gloves and work under a biological hood.
  3. Once cells reach about 80....

Access restricted. Please log in or start a trial to view this content.

Results

Total number of particles for single staining

Since a single bead can bind more than one particle, we tested different conditions to set the smallest amount of total EV (single antibody per tube) to reach the early exponential phase of MFI curve. A fixed concentration of antibody was used while the total number of particles ranged from 5 x 105 to 2.5 x 108. As shown in .......

Access restricted. Please log in or start a trial to view this content.

Discussion

Conventional FC technique remains the most straightforward analytic method to characterize markers expressed onto the surface of EV. In this regard, selecting the most appropriate protocol is crucial to obtain useful information on individual particle fractions of interest by avoiding limitations due to instrument sensitivity. We described a method using magnetic particles coupled with antibodies that recognize Exo and small EV surface antigens which are suitable for downstream FC application. We validated the method usi.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

Nothing to declare.

Acknowledgements

L.B. was supported by research grants of Helmut Horten Stiftung and Velux Stiftung, Zurich (Switzerland). G.V. was supported by research grants of Swiss National Science Foundation, the Cecilia-Augusta Foundation, Lugano, and the SHK Stiftung für Herz- und Kreislaufkrankheiten (Switzerland)

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
IMDMGibco12440061
Amicon Ultra-15, PLHK Ultracel-PL Membran, 100 kDa MilliporeUFC910024
CytoFlex, Flow Cytometer PlatformBeckman CoulterCytoFlex
DMEM, high glucose, HEPES, no phenol redGibco21063045
Dulbecco's PBS (PBS) Ca- and Mg-freeLonzaBE17-512F
ExoCap CD63 Capture KitJSR Life SciencesEx-C63-SP
ExoCap CD81 Capture KitJSR Life SciencesEx-C81-SP
ExoCap CD9 Capture KitJSR Life SciencesEx-C9-SP
Exosome-Depleted FBSThermofisherA2720801
Exosome-depleted FBS Media SupplementSBIEXO-FBS-250A-1
FBS-Fetal Bovine SerumGibco10270106
FITC anti-human CD9 AntibodyBiolegend312104           RRID: AB_2075894
Flow Cytometer analysis softwareBeckman CoulterKaluza
NanoSight LM10MalvernNanoSight LM10
NanoSight SoftwareMalvernNTA 2.3
Optima Max-XPBeckman Coulter393315
PE anti-human CD63 AntibodyBiolegend353004           RRID:AB_10897809
PE anti-human CD81 (TAPA-1) AntibodyBiolegend349505           RRID:AB_10642024
Penicillin-StreptomycinGibco15140122
Thermomixer CEppendorf5382 000 015
TLA-110Beckman CoulterTLA-110 rotors

References

  1. Barile, L., Vassalli, G. Exosomes: Therapy delivery tools and biomarkers of diseases. Pharmacology & Therapeutics. , (2017).
  2. Thery, C. Exosomes: secreted vesicles and intercellular communications. Molecular Biology Reports. 3, 15(2011).
  3. Yadav....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

Flow CytometryCardiac Progenitor CellsUltracentrifugationNanoparticle TrackingAntibody ConjugationMean Fluorescence IntensityCD63 CD9 CD81Bead-based Capture